Correction: Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?

In this article (Clin Cancer Res 2010;16:390–7), which was published in the January 15, 2010, issue of Clinical Cancer Research (1), there was an error in the median survival column in Table 2. The value for brivanib was misaligned and should have appeared as two values: 10 in the “First-line” row and 9.8 in the “Second-line” row. The online article has been changed to reflect this correction and no longer matches the print.